Efficacy of Switching Therapy From Alglucosidase Alfa to Avalglucosidase Alfa on Respiratory Function in Participants With Late‐Onset Pompe Disease: A Post Hoc Analysis From the COMET Trial

Documenti analoghi

• Efzimfotase Alfa Improves Respiratory Capacity in Muscle Tissue From a Mouse Model of HPP
  di: Denise Devore, et al.
  Pubblicazione: (2025)
• Elevated Transaminases: Does It Always Warrant a Liver Biopsy? Lessons Learned From Pompe Disease
  di: Alicia Khazzeka, et al.
  Pubblicazione: (2025)
• Early Initiation of Enzyme Replacement Therapy in Infantile Onset Pompe Disease Improves Cardiac Outcomes: A Longitudinal Analysis
  di: Jennifer L. Cohen, et al.
  Pubblicazione: (2026)
• A Mild Juvenile Onset Canavan Disease With Atypical Clinical Presentation and MRI Brain Features
  di: Preeya Rehsi, et al.
  Pubblicazione: (2025)
• 2‐[18F] FDG PET/CT in Rapid Late‐Onset Multiple Acyl‐CoA Dehydrogenase Deficiency: A Case Report
  di: Astrid Høj, et al.
  Pubblicazione: (2025)